GSK, Pfizer RSV shots to get warning of rare neurological disorder
by Contributor since / Followers
1 day ago
Hailshadow
The U.S. FDA is ordering that respiratory syncytial virus (RSV) vaccines marketed by GSK (NYSE:GSK) and Pfizer (NYSE:PFE) contain a warning on labeling of the risk of developing the rare neurological disorder Guillain-Barré syndrome (“GBS”).
